Covered recipient · General Payments record
KATELYN GALLOWAY PHILLIPS
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2022–2024
$1,179.16
- Reported across 66 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $305.10 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $83.86 | 4 |
| Lilly USA, LLC | $68.49 | 4 |
| Almatica Pharma Inc. | $47.41 | 3 |
| Novo Nordisk AS | $30.54 | 2 |
| Exact Sciences Corporation | $23.45 | 1 |
| Acerta Pharma LLC | $20.79 | 1 |
| PFIZER INC. | $17.05 | 1 |
| Phathom Pharmaceuticals, Inc. | $13.51 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.49 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107847309 | CMS |
| ABBVIE INC. | $21.58 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107847311 | CMS |
| ABBVIE INC. | $27.99 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107847313 | CMS |
| ABBVIE INC. | $16.80 | 11/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107847315 | CMS |
| Almatica Pharma LLC | $13.61 | 01/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137612705 | CMS |
| Almatica Pharma LLC | $14.60 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137612709 | CMS |
| Almatica Pharma LLC | $19.20 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137612713 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.79 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104284851 | CMS |
| Exact Sciences Corporation | $23.45 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114459969 | CMS |
| Lilly USA, LLC | $21.74 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135733636 | CMS |
| Lilly USA, LLC | $17.88 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135710942 | CMS |
| Lilly USA, LLC | $13.62 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135648969 | CMS |
| Lilly USA, LLC | $15.25 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135710944 | CMS |
| Novo Nordisk Inc | $13.97 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100420322 | CMS |
| Novo Nordisk Inc | $16.57 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100566242 | CMS |
| PFIZER INC. | $17.05 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131713305 | CMS |
| Phathom Pharmaceuticals, Inc. | $13.51 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151196883 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.